Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Therapeutic approaches for COVID-19: Myths and facts (AAC ed.)

    Therapeutic approaches for COVID-19: Myths and facts (AAC ed.)

    FromEditors in Conversation

    Start listeningView podcast show

    Therapeutic approaches for COVID-19: Myths and facts (AAC ed.)

    FromEditors in Conversation

    ratings:
    Length:
    31 minutes
    Released:
    Aug 4, 2020
    Format:
    Podcast episode

    Description

    Objectives: • Discuss the therapeutic options currently being used for COVID-19 • Evaluate some clinical data supporting the use of these drugs • Comment on clinical trials and enrollment Participants: • Andre Kalil, Professor, University of Nebraska Medical Center, Omaha, NB, USA. Lead Investigator, NIH Clinical Trial for COVId-19 • Miguel A. Martinez, Editor AAC. Professor, AIDS Research Institute-IrsiCaixa, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain. Visit https://aac.asm.org/ to browse issues and/or submit a manuscript.
    Released:
    Aug 4, 2020
    Format:
    Podcast episode

    Titles in the series (81)

    Editors in Conversation is the official podcast of the American Society for Microbiology Journals. Editors in Conversation features discussions between ASM Journals Editors, researchers and clinicians working on the most cutting edge issues in the microbial sciences. Topics include laboratory diagnosis and clinical treatment of infectious diseases, antimicrobial resistance, epidemiology of infections, multidrug-resistant organisms, pharmacology of antimicrobial agents, susceptibility testing, and more. The podcast is directed to microbiologists, infectious diseases clinicians, pharmacists and basic, clinical and translational researchers interested in the microbial sciences. A particular emphasis is on basic, epidemiological and pharmacological aspects of infectious diseases, including antimicrobial resistance and therapeutics.